Epigenetic Mechanisms Underlying the Pathogenesis of Myelodysplastic Syndrome (MDS) and Chronic Myelomonocytic Leukemia (CMML)

被引：0
|
作者：
Cheng, J. X.
Anastasi, J.
Shen, J. Q.
Watanabe, K.
Grimley, E.
Kleinbrink, E.
Knibbs, R.
Roulston, D.
Vardiman, J. W.
机构：
[1] Univ Michigan, Ann Arbor, MI 48109 USA
[2] Univ Chicago, Chicago, IL 60637 USA
[3] Univ Nevada, Las Vegas, NV 89154 USA
来源：
LABORATORY INVESTIGATION | 2012年 / 92卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1382
引用
收藏
页码：329A / 330A
页数：2
相关论文
共 50 条
  • [1] Epigenetic Mechanisms Underlying the Pathogenesis of Myelodysplastic Syndrome (MDS) and Chronic Myelomonocytic Leukemia (CMML)
    Cheng, J. X.
    Anastasi, J.
    Shen, J. Q.
    Watanabe, K.
    Grimley, E.
    Kleinbrink, E.
    Knibbs, R.
    Roulston, D.
    Vardiman, J. W.
    MODERN PATHOLOGY, 2012, 25 : 329A - 330A
  • [2] CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML) - A MYELODYSPLASTIC OR MYELOPROLIFERATIVE SYNDROME
    MICHAUX, JL
    MARTIAT, P
    LEUKEMIA & LYMPHOMA, 1993, 9 (1-2) : 35 - 41
  • [3] FLT3 mutations in myelodysplastic syndromes (MDS) and chronic myelomonocytic leukemia (CMML)
    Bhamidipati, Pavan Kumar
    Daver, Naval Guastad
    Kantarjian, Hagop
    Pierce, Sherry
    Daver, Roshni
    Cortes, Jorge E.
    Ravandi, Farhad
    Mathisen, Michael
    Pemmaraju, Naveen
    Nazha, Aziz
    Kadia, Tapan M.
    Jabbour, Elias
    Borthakur, Gautam
    Faderl, Stefan
    Garcia-Manero, Guillermo
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [4] Geno-Clinical Model to Aid in the Diagnosis of Myelodysplastic Syndrome (MDS) Versus Chronic Myelomonocytic Leukemia (CMML)
    Hilton, C. Beau
    Sekeres, Mikkael A.
    Meggendorfer, Manja
    Walter, Wencke
    Hutter, Stephan
    Padron, Eric
    Savona, Michael R.
    Gerds, Aaron T.
    Guan, Yihong
    Sallman, David A.
    Mukherjee, Sudipto
    Patnaik, Mrinal M.
    Smith, Brianna
    Nagata, Yasunobu
    Adema, Vera
    Hasipek, Metis
    Hirsch, Cassandra M.
    Przychodzen, Bartlomiej P.
    Komrokji, Rami S.
    Jha, Babal K.
    Haferlach, Claudia
    Maciejewski, Jaroslaw P.
    Haferlach, Torsten
    Nazha, Aziz
    BLOOD, 2018, 132
  • [5] Topotecan A topoisomerase 1 inhibitor induces complete remissions in myelodysplastic syndrome (MDS) and chronic myelomonocytic leukemia (CMML).
    Beran, M
    OBrien, S
    Estey, E
    Keating, M
    Kantarjian, H
    BLOOD, 1996, 88 (10) : 2308 - 2308
  • [6] Outcome of Patients (pts) with Myelodysplastic Syndrome (MDS) and Chronic Myelomonocytic Leukemia (CMML) Post Decitabine Failure.
    Jabbour, Elias
    Garcia-Manero, Guillermo
    Shan, Jianqin
    O'Brien, Susan
    Cortes, Jorge
    Ravandi, Farhad
    Issa, Jean-Pierre J.
    Kantarjian, Hagop M.
    BLOOD, 2008, 112 (11) : 585 - 586
  • [7] Incidence of myelodysplastic syndromes (MDS) and chronic myelomonocytic leukemia (CMML) in Norway 1993-2006
    Schoonen, W.
    Aagnes, B.
    Bray, F.
    Hansen, S.
    Fryzek, J.
    Weiderpass, E.
    LEUKEMIA RESEARCH, 2009, 33 : S64 - S64
  • [8] Risk-Adapted, Individualized Treatment Strategies of Myelodysplastic Syndromes (MDS) and Chronic Myelomonocytic Leukemia (CMML)
    Bewersdorf, Jan Philipp
    Zeidan, Amer M.
    CANCERS, 2021, 13 (07)
  • [9] RED BLOOD CELL (RBC) ALLOIMMUNIZATION AFTER BLOOD TRANSFUSION IN PATIENTS WITH MYELODYSPLASTIC SYNDROME (MDS) OR CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML)
    Nomdedeu, M.
    Sanz, C.
    Abello, D.
    Franquet, C.
    Cobo, F.
    Belkaid, M.
    Rozman, M.
    Aguilar, J. L.
    Nomdedeu, B.
    Pereira, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 132 - 132
  • [10] Spontaneous growth of CFU-GM in myelodysplastic syndromes (MDS): Should chronic myelomonocytic leukemia (CMML) be reclassified?
    Zittoun, J
    Giraudier, S
    Jouault, H
    Tulliez, M
    Ngo, MM
    Imbert, M
    BLOOD, 1999, 94 (10) : 107A - 107A
12345